Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice

Frontiers in Immunology(2020)10.3389/fimmu.2020.573677Source: DataRank Database

Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 32 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.16)OA: goldTopics (89)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Cody Lubinsky,Michelle Hand,Sabeeya Khan,Tulsi Patel ORCID,Alecia Seliga ORCID

Live enrichment

PubMed:33042154 PMC:PMC7522287 OpenAlex:https://openalex.org/W3092341073

NIAMS NIH HHS

Grant: R21 AR071679

NIDA NIH HHS

Grant: P30 DA013429

National Institutes of Health

Grant: 2P30DA013429-06

ADMINISTRATIVE CORE

National Institutes of Health

Grant: 5R21AR071679-02

Kallikrein-kinin system and Type I interferons in systemic and neurolupus

National Institutes of Health

FWCI

3.16

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.573677/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.573677/pdf

publisherhttps://www.frontiersin.org/article/10.3389/fimmu.2020.573677/full

journalhttps://doi.org/10.3389/fimmu.2020.573677

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33042154

Fields of Study

Systemic Lupus Erythematosus ResearchCoagulation, Bradykinin, Polyphosphates, and AngioedemaCytokine Signaling Pathways and Interactions0301 basic medicine03 medical and health sciences0303 health sciencesAdministration, OralAngiotensin-Converting Enzyme InhibitorsAnimalsAutoantibodiesBehavior, AnimalBrainCaptoprilCytokinesDisease Models, AnimalFemaleInflammation MediatorsInfusions, SubcutaneousInjections, IntraperitonealInterferon Regulatory FactorsInterferon-alphaKidneyLupus Vasculitis, Central Nervous SystemMice, Inbred MRL lprMicrogliaSignal TransductionSpleen

MeSH Terms

Administration, OralAngiotensin-Converting Enzyme InhibitorsAnimalsAutoantibodiesBehavior, AnimalBrainCaptoprilDisease Models, AnimalFemaleInjections, IntraperitonealKidneySpleenSignal TransductionCytokinesInterferon-alphaMicrogliaInflammation MediatorsMice, Inbred MRL lprLupus Vasculitis, Central Nervous SystemInterferon Regulatory FactorsInfusions, Subcutaneous

Keywords

CaptoprilSystemic lupus erythematosusMedicineImmunologyInflammationEndocrinologyInternal medicineImmune systemAngiotensin-converting enzymeBradykininReceptorDiseaseBlood pressureSerotoninDepressionType I interferonimmune complexangiotensin-converting enzyme inhibitorneuroinflammationLupus-prone MiceMice, Inbred MRL lprAdministration, OralAngiotensin-Converting Enzyme InhibitorsInfusions, SubcutaneousKidneyAnimalsAutoantibodiesBehavior, AnimalLupus Vasculitis, Central Nervous SystemBrainInterferon-alphaRC581-607Disease Models, AnimalInterferon Regulatory FactorsCytokinesFemaleMicrogliaImmunologic diseases. AllergyInflammation MediatorsInjections, IntraperitonealSignal Transduction

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice

FAIR Checklist

Authors (13)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)